Lynch Syndrome Integrative Epidemiology and Genetics (LINEAGE) Consortium Observational Study to Understand Cancer Risks and Gene Interactions in Lynch Syndrome

What this Trial Is About

Researchers are investigating Lynch Syndrome through the LINEAGE Consortium to improve the understanding and management of this genetic condition. The study aims to enhance knowledge about cancer risks, early detection, and prevention strategies for individuals with Lynch Syndrome by collecting comprehensive clinical and genetic data. This observational prospective cohort study focuses on individuals carrying genetic variants associated with Lynch Syndrome to better understand their cancer risk and outcomes. The study does not involve specific interventions but collects standardized clinical information, biospecimens, and genetic data from participants. It includes baseline and annual reviews of electronic health records, as well as surveys completed by participants and providers. Biosamples may be collected once or repeatedly from participants at participating centers to support research on Lynch Syndrome-related cancers. Participants will be followed over time with annual data collection to monitor health outcomes, including the incidence of colorectal cancer. Researchers will analyze clinical data, genetic information, and biospecimens to explore cancer risks, gene-environment interactions, and factors influencing disease progression. The study also supports collaborative research efforts by providing infrastructure for data sharing and grant applications, aiming to improve cancer prevention and early detection for Lynch Syndrome patients.

Lynch Syndrome Integrative Epidemiology and Genetics